PROMUS Element™ Plus H7493911416400Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3
All models of PROMUS Element Plus (44)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08714729808077), received between Apr 4, 2018 and Apr 4, 2018 — classified as 1 death.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Death1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
DeathApr 4, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
PROMUS ELEMENT PLUS CLINICAL STUDY IT WAS REPORTED THAT THE PATIENT DIED. IN (B)(6) 2013, THE PATIENT WAS DIAGNOSED WITH UNSTABLE ANGINA. SUBSEQUENTLY, THE PATIENT WAS REFERRED FOR CARDIAC CATHETERIZATION AND THE INDEX PROCEDURE WAS PERFORMED ON THE SAME DAY. THE TARGET LESION# 1 WAS LOCATED IN THE FIRST OBTUSE MARGINAL BRANCH WITH 80% IN-STENT RESTENOSIS OF A PREVIOUSLY DEPLOYED UNKNOWN DRUG-ELUTING STENT (DES) AND WAS 14MM LONG WITH REFERENCE VESSEL DIAMETER OF 4 MM. THE LESION WAS TREATED WITH PRE-DILATATION AND PLACEMENT OF A 4.00 X16MM PROMUS ELEMENT¿ PLUS DES. FOLLOWING POST DILATATION, RESIDUAL STENOSIS WAS 20%. ONE DAY POST PROCEDURE, THE PATIENT WAS DISCHARGED ON ASPIRIN AND TICAGRELOR. DURING THE 5-YEAR FOLLOW-UP, THE SITE BECAME AWARE THAT THE PATIENT WAS IN A NURSING HOME AND WAS NOT ASSESSABLE FOR THE FOLLOW-UP. THE PATIENT EXPIRED IN THE NURSING HOME ON AN UNKNOWN DATE OF UNKNOWN CAUSE.
Patient problems: Death
MAUDE report 7397992 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page